128 related articles for article (PubMed ID: 37696241)
1. Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study.
Duchesneau ED; McNeill AM; Schary W; Pate V; Lund JL
J Geriatr Oncol; 2023 Nov; 14(8):101602. PubMed ID: 37696241
[TBL] [Abstract][Full Text] [Related]
2. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
[TBL] [Abstract][Full Text] [Related]
3. Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia.
Lee TY; Johnson A; Cooke CE; Yared JA; Summers A; Yang K; Liu S; Tang B; Onukwugha E
J Manag Care Spec Pharm; 2024 May; 30(5):430-440. PubMed ID: 38701030
[TBL] [Abstract][Full Text] [Related]
4. Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries.
Bird ST; Tian F; Flowers N; Przepiorka D; Wang R; Jung TH; Kessler Z; Woods C; Kim B; Miller BW; Wernecke M; Kim C; McKean S; Gelperin K; MaCurdy TE; Kelman JA; Graham DJ
JAMA Oncol; 2020 Feb; 6(2):248-254. PubMed ID: 31855259
[TBL] [Abstract][Full Text] [Related]
5. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.
Steingrímsson V; Lund SH; Dickman PW; Weibull CE; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2022 Feb; 108(2):145-153. PubMed ID: 34714556
[TBL] [Abstract][Full Text] [Related]
6. Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.
Rotbain EC; Niemann CU; Rostgaard K; da Cunha-Bang C; Hjalgrim H; Frederiksen H
Leukemia; 2021 Sep; 35(9):2570-2580. PubMed ID: 33603143
[TBL] [Abstract][Full Text] [Related]
7. Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.
Ailawadhi S; Ravelo A; Ng CD; Shah B; Lamarre N; Wang R; Eakle K; Biondo JM
J Comp Eff Res; 2024 Feb; 13(2):e230119. PubMed ID: 38294335
[No Abstract] [Full Text] [Related]
8. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
9. Lifetime costs to Medicare of providing care to patients with chronic lymphocytic leukemia.
Lafeuille MH; Vekeman F; Wang ST; Kerrigan M; Menditto L; Duh MS
Leuk Lymphoma; 2012 Jun; 53(6):1146-54. PubMed ID: 22111902
[TBL] [Abstract][Full Text] [Related]
10. Chronic Lymphocytic Leukemia in the Elderly: Epidemiology and Proposed Patient-Related Approach.
Balducci L; Dolan D
Cancer Control; 2015 Oct; 22(4 Suppl):3-6. PubMed ID: 26618340
[TBL] [Abstract][Full Text] [Related]
11. Disparity in treatment patterns among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia: an analysis of patient and contextual factors.
Yared JA; Lee TY; Cooke CE; Johnson A; Summers A; Yang K; Liu S; Tang B; Onukwugha E
Leuk Lymphoma; 2024 May; 65(5):598-608. PubMed ID: 38323907
[TBL] [Abstract][Full Text] [Related]
12. Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database.
Satram-Hoang S; Reyes C; Hoang KQ; Momin F; Skettino S
Ann Hematol; 2014 Aug; 93(8):1335-44. PubMed ID: 24638841
[TBL] [Abstract][Full Text] [Related]
13. Life expectancy estimates based on comorbidities and frailty to inform preventive care.
Schoenborn NL; Blackford AL; Joshu CE; Boyd CM; Varadhan R
J Am Geriatr Soc; 2022 Jan; 70(1):99-109. PubMed ID: 34536287
[TBL] [Abstract][Full Text] [Related]
14. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Ferrajoli A; Danilov AV; Giordano SH
Blood Adv; 2023 Jun; 7(11):2632-2642. PubMed ID: 36753602
[TBL] [Abstract][Full Text] [Related]
15. Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare population.
Goyal RK; Nagar SP; Kabadi SM; Le H; Davis KL; Kaye JA
Cancer Med; 2021 Apr; 10(8):2690-2702. PubMed ID: 33734606
[TBL] [Abstract][Full Text] [Related]
16. Underweight, Markers of Cachexia, and Mortality in Acute Myocardial Infarction: A Prospective Cohort Study of Elderly Medicare Beneficiaries.
Bucholz EM; Krumholz HA; Krumholz HM
PLoS Med; 2016 Apr; 13(4):e1001998. PubMed ID: 27093615
[TBL] [Abstract][Full Text] [Related]
17. An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia.
Danese MD; Griffiths RI; Gleeson M; Satram-Hoang S; Knopf K; Mikhael J; Reyes C
Blood; 2011 Mar; 117(13):3505-13. PubMed ID: 21190994
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of chronic lymphocytic leukemia comorbidity index in a young population: a real-world evidence study of a national gulf region cohort.
Alshemmari SH; AlSarraf A; Kaempf A; Danilov AV
BMC Cancer; 2024 May; 24(1):584. PubMed ID: 38741031
[TBL] [Abstract][Full Text] [Related]
19. Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017).
Alrawashdh N; Sweasy J; Erstad B; McBride A; Persky DO; Abraham I
Ann Hematol; 2021 Oct; 100(10):2501-2512. PubMed ID: 34279676
[TBL] [Abstract][Full Text] [Related]
20. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
